Author

Y. Xuan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:benchmarking· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:metabolomics· 1 Research Focus:software / tool· 1

Frequent Co-Authors

A. Pashkova· 1 shared C. Murray· 1 shared C. P. Ong· 1 shared C.-L. Lee· 1 shared D. Li· 1 shared D. P. B. McGovern· 1 shared D. RUAN· 1 shared D.-Y. Jin· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. Pashkova

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Paradigm shift in biomarker translation: a pipeline to generate clinical grade biomarker candidates from DIA-MS discovery

Q. Fu, M. Vegesna, N. Sundararaman, E. Damoc, T. N. Arrey, A. Pashkova, E. Mengesha, P. Debbas, S. Joung, D. Li, S. Cheng, J. Braun, D. P. B. McGovern, C. Murray, Y. Xuan, J. E. Van Eyk

This paper introduces TEAQ, a software tool that selects clinical-grade biomarker candidates from DIA-MS data by evaluating protein quantification metrics in a discovery cohort.

bioRxiv · Mar 20, 2024 · PreprintBiochemistry

Human Early Syncytiotrophoblasts Are Highly Susceptible to SARS-CoV-2 Infection

P. Liu, D. RUAN, Z.-W. Ye, S. Yuan, Z. Li, W. Zhang, C. P. Ong, K. Tang, J. Guo, Y. Xuan, T. T. K. K. Tam, Y. Huang, Q. Zhang, C.-L. Lee, P. C. N. Chiu, , D.-Y. Jin

This paper shows that human early syncytiotrophoblasts are highly susceptible to SARS-CoV-2 infection via ACE2 and demonstrates antiviral efficacy of remdesivir and GC376.

bioRxiv · Nov 17, 2022Cell Biology